Skip to main content
. 2014 Mar;39(2):94–101.

Table 1.

Primary characteristics of the patients

   EPO group Control group P value
Number 22 21  
Gender 13 8 0.1
Age(year) 59.73±7.73 62.57±8.60 1.878
Smoking 14 13 0.4
Diabetes history 8 10 0.9
BMI(kg/m 2 ) 25.82±1.83 24.36±2.12 0.009
Creatinine (mg/dl) 0.94±0.18 0.86±0.27 0.149
Impaired  vessels(n) 2.27±0.787 2.29±0.784 0.863
EF before operation(n) 46.36±8.04 45.90±8.41 0.178
Hgb (g/dl) 12.64±2.10 13±1.20 0.955
Retic (%) 0.85±0.33 0.61±0.25 0.166
Na (mEq/L) 141.36±1.98 140.95±4.11 0.67
K (mEq/L) 4.20±0.35 4.45±0.44 0.594
FBS (mg/dl) 132.68±55.19 158.95±79.98 0.132
Pack cell (n) 1±1.06 0.48±0.68 0.021
Graft (n) 3.14±0.88 3.38±0.74 0.33
Pump time (min) 78.21±18.8 79.76±12.25 0.6
Cross-clamping time (min) 50.95±10.85 53.86±9.13 0.08

EPO: Erythropoietin; BMI: Body mass index; EF: Ejection fraction